Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | MEF2A |
| Upstream (Parents) |
|---|
| (<<) ADCY7 → MEF2A |
| (<<) CASP9 → MEF2A |
| (<<) CDR2 → MEF2A |
| (<<) CEP170 → MEF2A |
| (<<) CHST12 → MEF2A |
| (<<) ENC1 → MEF2A |
| (<<) EWSR1 → MEF2A |
| (<<) FZD5 → MEF2A |
| (<<) GLTPD1 → MEF2A |
| (<<) GNAI1 → MEF2A |
| (<<) GNB1 → MEF2A |
| (<<) GNG11 → MEF2A |
| (<<) PIK3R5 → MEF2A |
| (<<) PLA2G4A → MEF2A |
| (<<) SMAD5 → MEF2A |
| (<<) SPRY2 → MEF2A |
| (<<) SRC → MEF2A |
| (<<) WBP4 → MEF2A |
| Downstream (Children) |
|---|
| MEF2A → ASNS (>>) |
| MEF2A → ATP2B1 (>>) |
| MEF2A → CBFA2T3 (>>) |
| MEF2A → DVL3 (>>) |
| MEF2A → ENO3 (>>) |
| MEF2A → GRIN2D (>>) |
| MEF2A → MAP1B (>>) |
| MEF2A → MERTK (>>) |
| MEF2A → MMP3 (>>) |
| MEF2A → NFKBIE (>>) |
| MEF2A → NRIP1 (>>) |
| MEF2A → PLA2R1 (>>) |
| MEF2A → RORA (>>) |
| MEF2A → SALL2 (>>) |
